NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Wednesday that its fourth quarter revenues fell 12 percent year over year.

The Omaha, Neb.-based molecular diagnostics firm reported total revenues of $6.2 million for the three months ended Dec. 31, compared to $7.2 million for the fourth quarter of 2012. Its laboratory services revenue dropped to $2.8 million from $4.8 million, while its diagnostics tools business saw revenues rise to $3.4 million from $2.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.